albendazole has been researched along with Clinically Isolated CNS Demyelinating Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Y | 2 |
| Feng, F | 1 |
| Zheng, C | 1 |
| Zhou, Z | 1 |
| Jiang, M | 1 |
| Liu, Z | 1 |
| Xie, F | 1 |
| Sun, X | 2 |
| Wu, Z | 1 |
| Zeng, X | 1 |
| Li, WH | 1 |
| Wang, WC | 1 |
| Ou-Yang, LS | 1 |
| Lv, Z | 1 |
| Wu, ZD | 1 |
| Xiao, L | 1 |
| Xiao, B | 1 |
| Liang, JH | 1 |
3 other studies available for albendazole and Clinically Isolated CNS Demyelinating Syndrome
| Article | Year |
|---|---|
Tanshinone IIA attenuates demyelination and promotes remyelination in
Topics: Abietanes; Albendazole; Angiostrongylus cantonensis; Animals; Blotting, Western; Demyelinating Disea | 2019 |
Animal model of human disease with optic neuritis: neuropapillitis in a rat model infected with Angiostrongylus cantonensis.
Topics: Albendazole; Angiostrongylus cantonensis; Animals; Anthelmintics; Anti-Inflammatory Agents; Demyelin | 2014 |
[Clinical analysis of drug-induced demyelinating encephalopathy].
Topics: Adolescent; Adult; Albendazole; Child; Child, Preschool; Demyelinating Diseases; Encephalitis; Femal | 2000 |